An evaluation of the NOVA Celltrak 12 was performed over a 6-week peri
od. Precision, linearity, carryover, and reproducibility of values com
pared favorably to manufacturers' claims. The correlation was performe
d using the Coulter S Plus VI as the reference instrument and yielded
coefficients of correlation for measured parameters of greater than .9
8 with the exception of RDW at r = .84, MCV at r = 0.96, and MPV at r
= .92. Three-part differential information and an expanded flagging sy
stem affords increased clinical information and troubleshooting guides
. The three-part differential information compared favorably with that
of the Coulter S Plus VI with lymphocyte percentage r = .96, granuloc
yte percentage r = .94, and monocyte percentage r = .50. We conclude t
hat this instrument performed well in a clinical setting.